Therefore, the regulation of the TrkB/Akt/CREB/BDNF pathway and the Akt/Nrf-2/antioxidant enzyme in the brain may be a key point for the treatment or prevention of neurodegenerative diseases. Here, AKT1 is linked to neurodegenerative disease.